Stock screener

CRNX

Conviction 22HealthcareScan · Tue, Sep 8, 2026
CRNX$0.0000-100.00%
ResistanceSupportVol 14Insider sellCongress buyCongress sell
63 bars
Gilbert Cisneros
2
Vol MA14 2.53M
Jun 3Jun 22Jul 10Jul 28Aug 14Sep 1
Crinetics Pharmaceuticals, Inc.Biotechnologywww.crinetics.com ↗
Price0.0000
Change-100.00%
Gap-100.00%
Rel volume0.00×
Avg volume2.43M
Avg $ vol205.61M
SMA 2080.34
SMA 5074.13
SMA 20050.23
Price vs 50-100.00%
Price vs 200-100.00%
MA stackmixed
50/200 cross—
Supertrenddown · 26.13
RSI (14)4
MACD hist-6.23
MACD cross—
Stoch %K / %D0 / 61
ADX (14)82
+DI / −DI3 / 94
RSI divergenceBearish
MACD divergence—
ATR %—
ADR %0.20%
52w high84.95
52w low0.0000
From 52w high-100.00%
Above 52w low—
New 52w highNo
SqueezeOff
Bollinger width91.78%
%B-0.59
Donchian pos0.00%
Donchian high85.01
Donchian low0.0000
AVWAP (52w high)84.96
vs AVWAP high-100.00%
AVWAP (52w low)—
vs AVWAP low—
OBV trendUp
Chaikin MF (20)-0.18
Today vs 20d0.00×
Avg vol (14d)2.53M
Avg vol (20d)2.43M
Avg $ vol (20d)205.61M
Market cap0
RS 3m (vs SPY)-100.29%
RS 6m (vs SPY)-111.97%
RS line new highNo
Trend template3/8
Technical rank—
1 week-100.00%
1 month-100.00%
3 months-100.00%
6 months-100.00%
1 year-100.00%
YTD-100.00%
P/E0.00
P/B0.00
P/S0.00
P/FCF0.00
EPS-4.95
Div yield—
ROE-39.04%
ROA-35.20%
Debt/Eq—
Current15.57
EV/EBITDA0.11
Gross margin—
Net margin—
Rev growth640.71%
EPS growth-55.93%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value-55.5M
Revenue25.12M
Net income-120.86M
Gross profit—
Free cash flow-383.68M
IndustryBiotechnology
ExchangeNasdaq
Shares out105.44M
Employees594
ListedWed, Jul 18, 2018
Free float100.71M
Float %95.5%
Short interest6.59M
Days to cover3.1d
Short volume—
Squeeze score36 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction22 / 100
Pattern quality—
Tech rank—
Group rank96 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance84.27
Support83.82
Days since event—
Candle confirm—
News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in CRNX · 6 recent

All disclosures →
MemberSideAmount
Gilbert Cisneros
Gilbert Cisneros
house · D · CA · traded 2026-07-30
Sell$15K–$50K
Gilbert Cisneros
Gilbert Cisneros
house · CA · traded 2026-03-03
Buy$1K–$15K
Gilbert Cisneros
Gilbert Cisneros
house · D · CA · traded 2025-04-17
Buy$1K–$15K
Josh Gottheimer
Josh Gottheimer
house · D · NJ · traded 2025-03-19
Sell$1K–$15K
Gilbert Cisneros
Gilbert Cisneros
house · D · CA · traded 2025-01-29
Buy$1K–$15K
Josh Gottheimer
Josh Gottheimer
house · NJ · traded 2024-09-25
Buy$1K–$15K

Insider activity

SEC Form 4 transactions in CRNX · 10 sells

InsiderSideShares
Bedrosian Camille L
Director · Common Stock · 2026-09-01
Disposition5.92K
Bedrosian Camille L
Director · Common Stock · 2026-09-01
Disposition16.3K
Bedrosian Camille L
Director · Stock Option (Right to Buy) · 2026-09-01
Disposition25K
Bedrosian Camille L
Director · Stock Option (Right to Buy) · 2026-09-01
Disposition17.5K
Bedrosian Camille L
Director · Stock Option (Right to Buy) · 2026-09-01
Disposition17.5K
Bedrosian Camille L
Director · Stock Option (Right to Buy) · 2026-09-01
Disposition17.5K
Bedrosian Camille L
Director · Stock Option (Right to Buy) · 2026-09-01
Disposition12.5K
Bedrosian Camille L
Director · Stock Option (Right to Buy) · 2026-09-01
Disposition10.35K
Bedrosian Camille L
Director · Stock Option (Right to Buy) · 2026-09-01
Disposition9.73K
Betz Stephen F.
Chief Scientific Officer · Common Stock · 2026-09-01
Disposition58.29K

SEC filings

EDGAR filings in CRNX · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.